Background
Methods
Study population
Measurement of serum 25-OHD level
Immunosuppressive regimens
Statistical analysis
Results
Demographic features
25-OHD (ng/ml) | 13.1 ± 0.6 |
---|---|
Demographic characteristics | |
Recipient age (years) | 40.2 ± 1.1 |
Recipient gender (% women) | 31 (29.2) |
Active vitamin D supplementation before KT | 17 (16.0) |
Etiology of renal failure (%) | |
Diabetes mellitus | 10 (9.4) |
Glomerulonephritis | 32 (30.2) |
Hypertension and others | 64 (60.4) |
Duration of dialysis (months) | 16.8 ± 2.7 |
History of cardiovascular disease | 8 (7.5) |
Smoking | 22 (20.8) |
Body mass index (kg/m2) | 22.8 ± 0.3 |
Predominant RRT modality before KT (%) | |
Hemodialysis | 49 (46.2) |
Peritoneal dialysis | 22 (20.8) |
Pre-emptive transplantation | 35 (33.0) |
Transplant type | |
Living-related donor | 76 (71.7) |
Living-unrelated donor | 29 (27.4) |
Deceased donor | 1 (0.9) |
Donor characteristic | |
Donor age | 35.1 ± 1.0 |
Donor gender (% women) | 46 (43.4) |
ABO mismatch (%) | 15 (14.2) |
Number of HLA mismatches | 2.8 ± 0.1 |
Mismatch at A locus (%) | 83 (78.3) |
Mismatch at B locus (%) | 90 (84.9) |
Mismatch at DR locus (%) | 87 (82.1) |
Laboratory test results | |
Albumin (g/dl) | 3.8 ± 0.0 |
Calcium (mg/dl) | 9.1 ± 0.1 |
Albumin-corrected calcium (mg/dl) | 9.3 ± 0.1 |
Phosphorus (mg/dl) | 5.8 ± 0.2 |
Alkaline phosphatase (IU/l) | 68.6 ± 2.6 |
Parathyroid hormone (intact; pg/ml) | 204.6 ± 19.9 |
Osteocalcin (ng/ml) | 45.2 ± 4.0 |
Hemoglobin (g/l) | 9.5 ± 0.2 |
Biopsy-proven acute rejection episode | 11 (10.4) |
Distribution of 25-OHD concentrations
Without 25-OHD deficiency (n = 65) | With 25-OHD deficiency (n = 41) |
P- values | |
---|---|---|---|
25-OHD (ng/ml) | 16.7 ± 0.6 | 7.3 ± 0.3 | < 0.001 |
Demographic characteristics | |||
Recipient age (years) | 40.5 ± 1.3 | 39.9 ± 1.8 | 0.793 |
Recipient gender (% women) | 12 (18.5) | 19 (46.3) | 0.002 |
Active vitamin D supplementation before KT | 13 (20.0) | 4 (9.8) | 0.186 |
Etiology of renal failure (%) | |||
Diabetes mellitus | 5 (7.7) | 5 (12.2) | 0.440 |
Glomerulonephritis | 17 (26.2) | 15 (36.6) | 0.255 |
Hypertension and others | 43 (66.2) | 21 (51.2) | 0.126 |
Duration on dialysis (months) | 19.1 ± 3.7 | 13.3 ± 3.9 | 0.309 |
History of cardiovascular disease | 5 (7.7) | 3 (7.3) | 0.943 |
Smoking | 15 (23.1) | 7 (17.1) | 0.458 |
Body mass index (kg/m2) | 23.2 ± 0.4 | 22.2 ± 0.4 | 0.102 |
Predominant RRT modality before KT (%) | |||
Hemodialysis | 42 (64.6) | 7 (17.1) | < 0.001 |
Peritoneal dialysis | 6 (9.2) | 16 (39.0) | < 0.001 |
Pre-emptive transplantation | 17 (26.2) | 18 (43.9) | 0.058 |
Transplant type | |||
Living-related donor | 44 (67.7) | 32 (78.0) | 0.249 |
Living-unrelated donor | 20 (30.8) | 9 (22.0) | 0.321 |
Deceased donor | 1 (1.5) | 0 (0.0) | 1.000 |
Donor characteristic | |||
Donor age | 35.2 ± 1.4 | 35.0 ± 1.5 | 0.922 |
Donor gender (% women) | 36 (56.3) | 23 (56.1) | 0.988 |
ABO mismatch (%) | 12 (18.8) | 3 (7.3) | 0.153 |
Number of HLA mismatches | 2.9 ± 0.2 | 2.8 ± 0.2 | 0.753 |
Mismatch at A locus (%) | 49 (76.6) | 34 (82.9) | 0.434 |
Mismatch at B locus (%) | 55 (85.9) | 35 (85.4) | 0.935 |
Mismatch at DR locus (%) | 52 (81.3) | 35 (95.4) | 0.585 |
Biopsy-proven acute rejection episode | 2 (3.1) | 9 (22.0) | 0.003 |
Laboratory test results | |||
Albumin (g/dl) | 4.0 ± 0.1 | 3.6 ± 0.1 | < 0.001 |
Calcium (mg/dl) | 9.4 ± 0.1 | 8.7 ± 0.2 | 0.004 |
Albumin-corrected calcium (mg/dl) | 9.4 ± 0.1 | 9.1 ± 0.2 | 0.121 |
Phosphorus (mg/dl) | 6.0 ± 0.3 | 5.5 ± 0.2 | 0.169 |
Alkaline phosphatase (IU/l) | 68.9 ± 3.3 | 68.0 ± 4.4 | 0.864 |
Parathyroid hormone (intact; pg/ml) | 205.4 ± 26.9 | 203.2 ± 29.2 | 0.957 |
Osteocalcin (ng/ml) | 47.7 ± 5.4 | 41.2 ± 5.5 | 0.429 |
Hemoglobin (g/l) | 9.8 ± 0.2 | 9.0 ± 0.3 | 0.028 |
Pretransplant parameters | B | S.E. | Wald |
df
|
P- values | OR | 95% CI |
---|---|---|---|---|---|---|---|
Female sex vs. male) | 1.19 | 0.47 | 6.60 | 1 | 0.010 | 3.30 | 1.33-8.21 |
Serum albumin (per 1 mg/dl increase) | −1.04 | 0.52 | 3.96 | 1 | 0.047 | 0.13-0.98 | |
Predominant RRT modality before KT | 13.66 | 2 | < 0.001 | 0.35 | |||
HD (vs. PD) | −2.31 | 0.65 | 12.64 | 1 | < 0.001 | 0.10 | 0.03-0.36 |
Preemptive KT (vs. PD) | −0.96 | 0.60 | 2.56 | 1 | 0.110 | 0.38 | 0.12-1.24 |
Changes in eGFR
Between-subjects factors |
df
| F |
P-values |
---|---|---|---|
Recipient gender | 1 | 3.03 | 0.085 |
Predominant RRT modality before KT | 2 | 2.50 | 0.087 |
Biopsy-proven acute rejection episode | 1 | 1.83 | 0.179 |
25-OHD deficiency | 1 | 12.07 | 0.001 |